Neuraminidase inhibitors-the story behind the Cochrane review

被引：58

作者：

Doshi, Peter ^{[1
]}

机构：

[1] MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 339卷

关键词：

IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; ACUTE INFLUENZA; OSELTAMIVIR; RECOMMENDATIONS; PREVENTION; EFFICACY; SAFETY;

D O I：

10.1136/bmj.b5164

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1348 / 1351

页数：10

共 26 条

[1]

Abraham J., 1995, SCI POLITICS PHARM I

[2]

[Anonymous], 2005, HHS PAND INFL PLAN

[3]

BROWNLEE S, 2009, ATLANTIC NOV

[4] Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis [J].

Burch, Jane ;

Corbett, Mark ;

Stock, Christian ;

Nicholson, Karl ;

Elliot, Alex J. ;

Duffy, Steven ;

Westwood, Marie ;

Palmer, Stephen ;

Stewart, Lesley .

LANCET INFECTIOUS DISEASES, 2009, 9 (09) :537-545

[5] Does this patient have influenza? [J].

Call, SA ;

Vollenweider, MA ;

Hornung, CA ;

Simel, DL ;

McKinney, WP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08) :987-997

[6]

*CHUG PHARM CO, 2009, PROD INF

[7]

Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1

[8]

*HOFFM LA ROCH, 2008, PROD LAB

[9]

HOFFMANLAROCHE, 2005, INVESTOR UPDATE TAMI

[10]

HUSEREAU DR, 2002, 7 CCOHTA

← 1 2 3 →